Joyce Cheung-flynn
-
Research Snapshot: New drug targets vascular inflammation, drastically improving the long-term effectiveness of vascular procedures
Therapeutic MK2i-NP blocks both inflammation and an unhealthy conversion of cells in blood vessels after cardiovascular procedures, reducing the need for further interventions—cutting costs and reducing risks. Est. reading time: 2.5 minutes. Read MoreOct 11, 2021
-
New strategy to treat brain bleeding
Vasorelaxing peptides could offer a promising therapeutic strategy for reducing the neurological deficits caused by subarachnoid hemorrhage-induced cerebral blood vessel constriction. Read MoreMay 4, 2021